Parkinson’s research group expands to Dayton area

Premier Health and Wright State University are now part of a group that does Parkinson’s drug trials.

Parkinson’s Study Group is the largest nonprofit network of Parkinson centers in North America and being a part of the network could let local residents with the neurodegenerative disorder access to medications during the clinical trial phase and are not yet approved to go to market.

RELATED: Proposed law would ban forcing Ohio nurses to work overtime

The trials covers all associated costs.

“This is an honor for our site and also an incredible opportunity for Parkinson’s patients in Southwest Ohio,” stated Dr. Mary Feldman, a neurologist with Premier Health who specializes in movement disorders. “We are talking about having free access to trials focused on neuroprotection. That means medications that work to change the course of the disease rather than just treat the symptoms.”

Parkinson’s disease affects one million Americans, with symptoms that often progress over a course of years and could include a tremor mainly at rest, slowness of movement, limb rigidity, and gait and balance issues.

RELATED: Need a job? Dayton career fair planned Friday

Premier Health stated it is already an active site for Parkinson’s disease clinical trials and the participation in the group will allow for additional opportunities for Parkinson’s patients in the Dayton area.

Patients who are interested in participating in a trial can contact the Clinical Neuroscience Institute at 844-277-2894.

About the Author